Blog Big Molecule Watch December 09, 2015

BREAKING NEWS: D. Ct. Rules BPCIA 180-day Notice is Mandatory for Apotex’s pegfilgrastim product, Grants Preliminary Injunction in Amgen v. Apotex

The order can be found here.  Analysis to follow shortly.